Caribou Biosciences (CRBU) Current Assets (2020 - 2026)
Caribou Biosciences' Current Assets came in at $116.6 million for Q2 2026, down 39.4% from $192.51 million a year earlier and down 4.7% from the prior quarter.
Caribou Biosciences (CRBU) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Caribou Biosciences' Current Assets was $145.23 million, down 33.8% from FY2024.
- Current Assets carries a five-year compound annual growth rate of 43.0% (FY2020 to FY2025).
- Going back by year, Current Assets was $219.38 million in FY2024 (-35.3%), $338.84 million in FY2023 (+30.2%), $260.25 million in FY2022 (-33.5%) and $391.19 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Current Assets since Q4 2020.
- Year-over-year, Current Assets has declined for eight consecutive quarters, with an average decline of 34.6% over the last eight quarters.
- The fastest year-over-year change in Current Assets over five years came in Q2 2022 (growth of 146.9%), and the weakest in Q1 2026 (a decline of 43.7%).
- Business Quant data shows CRBU's Current Assets at $122.38 million (Q1 2026), $145.23 million (Q4 2025) and $155.51 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Caribou Biosciences | 130.37 Mn | -386.16 Mn | - | 116.60 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 116.60 Mn |
| Mar 31, 2026 | 122.38 Mn |
| Dec 31, 2025 | 145.23 Mn |
| Sep 30, 2025 | 155.51 Mn |
| Jun 30, 2025 | 192.51 Mn |
| Mar 31, 2025 | 217.32 Mn |
| Dec 31, 2024 | 219.38 Mn |
| Sep 30, 2024 | 237.43 Mn |
| Jun 30, 2024 | 270.88 Mn |
| Mar 31, 2024 | 304.51 Mn |
| Dec 31, 2023 | 338.84 Mn |
| Sep 30, 2023 | 350.69 Mn |
| Jun 30, 2023 | 268.54 Mn |
| Mar 31, 2023 | 239.49 Mn |
| Dec 31, 2022 | 260.25 Mn |
| Sep 30, 2022 | 306.92 Mn |
| Jun 30, 2022 | 352.93 Mn |
| Mar 31, 2022 | 368.01 Mn |
| Dec 31, 2021 | 391.19 Mn |
| Sep 30, 2021 | 449.05 Mn |
Caribou Biosciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CRBU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();